0001209191-23-012784.txt : 20230224
0001209191-23-012784.hdr.sgml : 20230224
20230224170553
ACCESSION NUMBER: 0001209191-23-012784
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230223
FILED AS OF DATE: 20230224
DATE AS OF CHANGE: 20230224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KEEFE MICHELLE
CENTRAL INDEX KEY: 0001766036
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36730
FILM NUMBER: 23668525
MAIL ADDRESS:
STREET 1: C/O SYNEOS HEALTH,INC.
STREET 2: 1030 SYNC STREET
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syneos Health, Inc.
CENTRAL INDEX KEY: 0001610950
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 273403111
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1030 SYNC STREET
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-876-9300
MAIL ADDRESS:
STREET 1: 1030 SYNC STREET
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: INC Research Holdings, Inc.
DATE OF NAME CHANGE: 20140616
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-23
0
0001610950
Syneos Health, Inc.
SYNH
0001766036
KEEFE MICHELLE
C/O SYNEOS HEALTH, INC.
1030 SYNC STREET
MORRISVILLE
NC
27560
1
1
0
0
Chief Executive Officer
Class A Common Stock
2023-02-23
4
A
0
4627
0.00
A
195473
D
Class A Common Stock
2023-02-23
4
A
0
1203
0.00
A
196676
D
Class A Common Stock
2023-02-23
4
A
0
3371
0.00
A
200047
D
Class A Common Stock
2023-02-23
4
F
0
3338
38.25
D
196709
D
Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022.
Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full on the date on which the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.
Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2022 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2024, subject to continued employment.
/s/ Sara Epstein, Attorney-in-Fact
2023-02-24